Capital Raising · Deal Structure

How Early-Stage CPG Brands Actually Raise Capital

Every structure available to an emerging food or beverage brand — from the first dollar to Series A — mapped to the stage where each one genuinely makes sense.

I reviewed a convertible note offering recently for an early-stage beverage brand. Clean structure, appropriate terms for the stage. But it got me thinking about how many founders approach their first raise — and even their second and third — with a limited view of what's actually available to them.

The mistake is thinking about capital in binary terms. Equity or debt. Investors or bootstrapping. In reality, the capital landscape for an emerging CPG or food brand is much wider than that — and the right structure at any given moment depends almost entirely on what stage you're at, what you can actually qualify for, and what you're willing to give up in exchange.

This article is a working guide to every realistic capital structure available to an emerging food or beverage brand, organized by stage — from the moment you have an idea and a prototype through your first institutional round. This is the article I wish existed when I was sitting across the table from early-stage founders trying to figure out how to get their first real check.

"The cheapest capital you will ever raise is the kind you don't have to give equity for. Exhaust that option first. Then dilutive capital. Then expensive debt. The sequence matters more than most founders realize."

LJ Govoni — Principal Consultant, Split Oak Advisory Group
01
Pre-revenue — the idea and prototype stage
$0 to ~$250K raised · No or minimal revenue

At this stage you have a product, a vision, and not much else. Valuations are essentially impossible to defend, which means any structure that requires setting one is the wrong tool. The goal here is to get to first sales with as little dilution as possible — which means leaning hard on non-dilutive capital before you touch equity.

Bootstrapping and personal capital
Non-dilutive Always available

Your own savings, personal credit, and sweat equity are the first dollars into any business. This is not just a necessity — it is also a signal. Every institutional investor you will ever meet wants to know that you have skin in the game before they put theirs in. A founder who has not committed meaningful personal capital to the business is a difficult pitch to make.

Practically, this means funding your first production run, your packaging design, your initial DTC website, and your first sales effort from personal resources wherever possible. The less equity you dilute before you have proof of demand, the better every subsequent raise will be.

Friends and family round
Dilutive or debt Common

Friends and family capital is the most common source of first outside money for CPG startups. It can be structured as a simple loan with interest and a repayment schedule, a SAFE, a convertible note, or straight equity — depending on the sophistication of the investors and the relationship.

The most important thing about a friends and family round is that it is documented properly regardless of how informal the relationship feels. A simple promissory note for loans, or a standard SAFE or convertible note template for equity-linked instruments, protects everyone — the founder and the investor — and prevents the relationship from becoming complicated when the business grows, stumbles, or both. Do not do this on a handshake, even with your closest people.

Grants, pitch competitions, and innovation prizes
Non-dilutive Underutilized

Non-dilutive grants are the most underutilized capital source in the early CPG market. USDA Value-Added Producer Grants, SBIR/STTR grants for food technology innovation, state agricultural development funds, women- and minority-owned business programs, and economic development grants through organizations like the SBA are all real sources of capital that require no equity and no repayment.

Pitch competitions — from small local events to national competitions run by organizations like Specialty Food Association, Whole Foods, or Target's forward-thinking retail programs — can provide $5K to $100K in non-dilutive cash plus exposure, mentorship, and retail relationships that are worth considerably more than the prize. The application process is real work, but it is capital that costs you nothing except time.

Accelerator and incubator programs
Dilutive Common

CPG-focused accelerators — including programs run by SKU, Chobani Incubator, Whole Foods Local Producer Loan Program, Target Takeoff, and regional food innovation hubs — provide early-stage brands with a combination of capital ($25K–$150K is typical), mentorship, retail relationships, co-manufacturing connections, and credibility. The cost is equity — typically 5–10% — plus the time commitment of the program itself.

For a brand at the zero-to-one stage, the non-capital value of the right accelerator often exceeds the financial value significantly. A warm introduction to a retail buyer from an accelerator that the buyer trusts is worth more to a $200K-revenue brand than the check. Choose the program based on what it connects you to, not just how large the investment is.

Crowdfunding — rewards-based (Kickstarter, Indiegogo)
Non-dilutive Common

Rewards-based crowdfunding lets you pre-sell product in exchange for early delivery or exclusive perks — no equity, no debt, no repayment if you hit your goal. For the right product, it is also a market validation tool: a successful campaign is proof of demand that you can show to every subsequent investor. A failed campaign tells you something important too.

The key is that campaigns that succeed are not passive — they require significant marketing effort before and during the campaign, a built-in community or email list to seed the launch, and a product that is visually compelling enough to convert strangers into backers. For food and beverage specifically, the product needs to be genuinely novel or have a strong enough story that people will pay before they taste it.

Stage 1 reality check: The single biggest mistake at this stage is taking dilutive equity before you have anything to prove value. A $100K friends and family round at a $1M valuation gives away 10% of your company at a time when you have almost no data. That same 10% at a $5M valuation — which is achievable with $500K in revenue and a retail account — is worth five times more. Delay equity as long as you can at this stage. Exhaust non-dilutive options first.
02
Pre-seed — early traction, proving the model
$250K–$1.5M raised · $0–$1M in revenue

You have product-market fit — or a credible early signal of it. You have some sales data. You know your COGS well enough to understand whether the unit economics can work. This is when outside capital starts to make sense, and when the structure of how you raise it starts to matter a great deal.

SAFE — Simple Agreement for Future Equity
Converts to equity Gaining traction in CPG

The SAFE was created by Y Combinator as a simpler alternative to the convertible note. The investor gives you money today in exchange for the right to receive equity at your next priced round — at a valuation cap, a discount, or both. There is no interest rate, no maturity date, and no obligation to repay. It is not debt. It is a contractual right to future equity.

SAFEs are the dominant instrument for pre-seed rounds in the startup ecosystem and are gaining meaningful adoption in CPG, particularly with angel investors and seed funds who are comfortable with the structure. The appeal is simplicity and speed: a standard post-money SAFE can be documented in a few pages and closed in days.

The risk founders underestimate: SAFEs accumulate. If you raise $150K on a SAFE, then another $200K on a SAFE a year later, then another $100K from an accelerator — you have $450K in SAFEs that all convert simultaneously at your priced round, creating a larger dilution event than any individual instrument suggested. Model the fully diluted cap table before every SAFE issuance.

Convertible note
Converts to equity Most common early CPG instrument

A convertible note is a short-term loan — typically 18 to 24 months — that converts to equity at a future priced round at a discount to the round price and/or subject to a valuation cap. Unlike a SAFE, it is actual debt: it accrues interest (typically 5–8% simple), has a maturity date, and if no conversion event occurs before maturity, the note is technically due — which is why maturity extension provisions and conversion triggers matter.

Convertible notes are the workhorse of early CPG financing. Institutional food and beverage investors are more familiar and comfortable with them than SAFEs, particularly for rounds above $200K where investors want the interest accrual and the maturity date as additional protections. At the pre-seed stage in CPG, if you are raising from sophisticated angels or early-stage food funds, expect the conversation to be about a convertible note.

Key terms to negotiate: the valuation cap (the maximum valuation at which the note converts regardless of round price), the discount rate (15–25% is standard), the interest rate, and what happens at maturity if no priced round has occurred. Most notes include a provision allowing holders to convert at maturity at the cap price — understand that provision before you sign.

Angel investors and angel networks
Dilutive Common

Individual angels — high-net-worth individuals investing their own capital — are the most active source of pre-seed and seed funding for CPG brands. In food and beverage, the most valuable angels are operators: former founders, brand builders, retail buyers, and distribution executives who understand the category and bring more than a check.

Angel networks pool individual investors to participate in rounds that would be too large for a single angel, while distributing due diligence and relationship management across the group. Networks like CircleUp, CAVU's angel network, and regional food and agriculture-focused angel groups provide access to a broader pool of informed, patient capital than cold outreach to individual investors typically delivers.

Angels typically invest via SAFEs or convertible notes at pre-seed — rarely via priced equity, which is reserved for seed rounds and beyond where there is enough data to support a real valuation negotiation.

Equity crowdfunding (Reg CF)
Dilutive Growing in CPG

Regulation Crowdfunding (Reg CF) allows brands to raise up to $5M per year from non-accredited investors through platforms like Wefunder, Republic, and StartEngine. Investors receive equity — typically at a fixed price — and become shareholders in the business.

For CPG brands with an engaged customer community, equity crowdfunding is a uniquely powerful instrument because it converts customers into shareholders with a financial stake in the brand's success. That community becomes a marketing and advocacy asset, not just a cap table entry. Several food and beverage brands have raised $500K to $2M via Reg CF while simultaneously deepening their customer relationships in a way that no institutional investor can replicate.

The tradeoff is operational overhead: disclosure requirements, ongoing SEC reporting, and managing a large number of small shareholders. Platforms charge fees of 5–8% of capital raised. And the cap table becomes complex — something future institutional investors will need to be comfortable with before they invest.

Stage 2 reality check: The convertible note and SAFE are functionally similar instruments — the key difference is that a note is debt and a SAFE is not. In CPG specifically, institutional investors tend to prefer convertible notes because they have operated in the space long enough to be skeptical of SAFEs for rounds above $200K. Know your investor's preference before you draft the term sheet. And in either case: model every conversion scenario before you agree to the cap.
03
Seed round — scaling what works
$1M–$3M raised · $500K–$3M in revenue

You have enough data to start defending a valuation. You have velocity data from retail or DTC, a unit economics story that holds up, and distribution traction that points toward a real growth path. This is when institutional seed investors start paying attention — and when the structure of the raise shifts from deferring the valuation conversation to having it.

Seed equity round (priced)
Dilutive Standard at this stage

A priced seed round sets a valuation, issues new preferred shares at a price per share, and creates a formal cap table entry for each investor. This is when terms like liquidation preference, anti-dilution protection, information rights, and pro-rata rights start to matter — because you are now dealing with investors who will hold these rights through multiple subsequent rounds.

For CPG brands, seed-stage institutional investors typically want to see $500K to $1M in annual revenue with an improving gross margin trajectory, meaningful velocity at retail (turns per store per week), and a clear argument for why the brand has category-defining potential. The bar has risen significantly in 2025 and 2026 — investors who were writing $500K seed checks into brands with $200K in revenue two years ago are now expecting $1M to $2M before engaging.

Typical seed round terms: 15–25% equity stake, $3M–$8M pre-money valuation, 1x non-participating liquidation preference, standard information and pro-rata rights. Lead investor negotiation is the critical path — most seed rounds cannot close without a lead, and finding the right lead takes longer than most founders budget for.

Strategic investment — corporate venture and retailer programs
Dilutive Active in current market

Strategic investors — large CPG companies, distributors, retailers, or ingredient suppliers with venture arms — are increasingly active in the emerging brand space in 2026 as M&A activity in food and beverage picks up. A strategic investment provides capital plus something potentially more valuable: distribution access, co-manufacturing capacity, retail relationships, or ingredient supply advantages that pure financial investors cannot offer.

The considerations are more complex than a financial investment. A strategic investor with a path to acquisition is a fundamentally different partner than a financial investor. You need to understand whether the investment creates exclusivity provisions, non-compete obligations, rights of first refusal, or information-sharing requirements that could constrain your optionality with other investors or acquirers. Read every provision carefully and get experienced legal counsel before signing.

Seed-stage CPG venture funds
Dilutive Common

A growing number of venture funds specialize specifically in early-stage consumer and CPG brands — CAVU Consumer Partners, Siddhi Capital, S2G Ventures, AF Ventures, Cleveland Avenue, and others. These firms understand food and beverage economics, retail mechanics, and the path from emerging brand to strategic acquisition in a way that generalist VCs rarely do.

The right CPG-specific fund brings more than capital: distribution introductions, co-manufacturer relationships, retail buyer relationships, and a network of portfolio companies whose collective experience in the category is genuinely useful. For a brand at the seed stage, that operational value matters as much as the check. The wrong fund — one that treats a food brand like a SaaS company and measures it on metrics that don't apply — can do real damage to how the company is managed and how the next round gets set up.

Stage 3 reality check: This is the round where the cap table from all your earlier SAFEs, convertible notes, and accelerator equity comes due. Every deferred instrument converts simultaneously when you set the price. Founders who have not modeled this are frequently shocked by how much dilution happens at the seed round close before the new investors even come in. Run the fully diluted cap table before you set the valuation — not after.
04
Series A — institutional scale
$3M–$15M raised · $2M–$8M in revenue

Series A is institutional capital at scale. The bar in 2026 for a CPG brand is higher than it was two years ago — investors want to see $1M to $3M in annual revenue with proven unit economics, meaningful wholesale distribution, and a brand that has demonstrated category-level potential, not just a good product. This is not a round for brands still figuring out their model. It is capital to scale something that is already working.

Series A priced equity round
Dilutive Standard

A Series A is a fully priced preferred equity round led by an institutional investor — a venture fund, a growth-stage CPG fund, or a private equity firm specializing in emerging consumer brands. The lead investor sets the terms, takes a board seat (or at minimum a board observer seat), and typically invests $2M to $8M with the expectation of follow-on capacity in subsequent rounds.

Series A terms are more complex than seed terms. Participation rights on the liquidation preference, weighted-average anti-dilution protections, drag-along and tag-along provisions, and detailed information and approval rights are standard. The governance implications of a Series A are material — understand what decisions require board or investor approval before the term sheet is signed.

The founder dilution at Series A typically runs 20–30%, but the cumulative dilution from all prior rounds, SAFEs, notes, accelerator equity, and option pool increases means the founder's ownership at Series A close is often significantly lower than it appears from the Series A terms alone. Founders who have managed their early-stage dilution carefully arrive at Series A with considerably more leverage than those who did not.

Revenue-based financing (non-dilutive bridge)
Non-dilutive Growing

For brands approaching Series A that have predictable revenue but need capital to bridge to the close or fund a specific growth initiative without diluting further, revenue-based financing has become a genuine option. Providers like Clearco and Assembled Brands advance capital in exchange for a fixed percentage of monthly revenue until a repayment cap — typically 1.3x to 1.8x the advance — is reached.

The appeal is pure: no dilution, no board seat, no governance implications, repayment that flexes with revenue. The cost is real — the implied APR can be high depending on repayment speed — and the monthly revenue commitment can create cash flow pressure if growth slows during the repayment period. It is a tool, not a strategy. Used precisely for a defined short-term need, it works well. Used to substitute for equity that the business actually needs to operate, it creates problems.

Stage 4 reality check: The CPG brands that arrive at Series A in the strongest position are almost always the ones that managed dilution carefully from the beginning — started with non-dilutive capital, used SAFEs and notes only when necessary, chose their early investors for strategic value rather than just check size, and kept a clean cap table that doesn't frighten institutional investors. The raise itself is the outcome of the decisions made in stages one through three. You can't fix a messy cap table at Series A — you can only work around it.

The Universal Principles That Apply at Every Stage

Five things that are true at every stage of the raise

  • Non-dilutive capital first, always. Grants, competitions, and government programs are underutilized. Every percentage point of ownership you preserve before your first institutional raise is worth significantly more at exit.
  • Model the cap table before every issuance. SAFEs and convertible notes feel small when you issue them. They feel large when they all convert simultaneously at your seed round. Run the fully diluted scenario before signing anything.
  • Investors are not interchangeable. The check is the least important thing many early investors bring. Network, retail relationships, operational expertise, and follow-on capacity matter more at the stages where you most need the help.
  • Documentation protects everyone. A handshake deal with a family member becomes a legal problem when the business is worth something. Use standard templates — SAFEs, notes, promissory note agreements — even with people you trust completely.
  • The structure should match the use of capital. Working capital and inventory should not be funded with long-term equity if there are non-dilutive alternatives. The right structure for the right purpose costs less over time than the convenient structure for everything.
This article is intended for general informational purposes only and does not constitute legal, tax, or investment advice. Capital structure decisions involve complex legal and financial considerations that vary by business, jurisdiction, and individual circumstance. Founders should consult qualified legal counsel and financial advisors before entering into any capital transaction. Split Oak Advisory Group provides financial and operational advisory services and does not act as a broker-dealer, placement agent, or registered investment advisor.

Ready to talk about your raise?

No sales process. No pitch deck. A direct conversation about where your business is, what you're trying to raise, and whether Split Oak can help you get there.

Start a Conversation
Your Financial Model Is Not a Fundraising Deck. It's a Road Map.